dipyridamole has been researched along with Eye Disorders in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole was introduced decades ago as a treatment for angina, subsequently found to inhibit platelet aggregation." | 2.53 | Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration. ( Barishak, YR; Ingram, A; Isakov, I; Rogosnitzky, M; Wlassoff, W, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rogosnitzky, M | 1 |
| Isakov, I | 1 |
| Wlassoff, W | 1 |
| Ingram, A | 1 |
| Barishak, YR | 1 |
| Romem, M | 1 |
| Singer, L | 1 |
| Friedman, C | 1 |
| Cuéllar Suárez, A | 1 |
| García Sánchez, J | 1 |
1 review available for dipyridamole and Eye Disorders
| Article | Year |
|---|---|
Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration.
Topics: Administration, Ophthalmic; Dipyridamole; Drug Administration Routes; Eye Diseases; Humans; Vasodila | 2016 |
2 other studies available for dipyridamole and Eye Disorders
| Article | Year |
|---|---|
[Intraocular hemorrhage due to systemic drugs].
Topics: Adult; Aged; Aspirin; Dipyridamole; Eye Diseases; Female; Hemorrhage; Humans; Male; Middle Aged; Qui | 1982 |
[Tonographic changes caused by dipyridamol].
Topics: Aqueous Humor; Arteriosclerosis; Dipyridamole; Eye Diseases; Humans; Injections, Intravenous; Intrao | 1969 |